Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing the previous v3.6.0, indicating a minor system update to the study page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now indicates that no participants are being recruited. New help and navigation entries were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated along with a revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check33 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning rather than substantive content changes.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record now shows revision v3.5.4, replacing the previous v3.5.3. This signals a minor update to the page content rather than a change to the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without altering the displayed study details.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.